Intero Biosystems
Miniature Human Organs for Preclinical Drug Development
Sugar Land, United States · Founded 2024
- Headquarters
- Sugar Land, Texas
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- interobiosystems.com
- Last Round
- Pre-SeedJun 2025
About
Intero Biosystems develops gut organoid technology — miniaturized, lab-grown intestinal tissue models — for use in personalized medicine and pharmaceutical drug testing. The company's platform enables more accurate preclinical testing by using patient-derived tissue to predict individual drug responses, reducing reliance on animal models and improving drug development success rates.
Summary
Intero Biosystems is a Healthcare company based in Sugar Land, United States, founded in 2024. Its most recent funding was a Pre-Seed round in Jun 2025.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/intero-biosystems"><img src="https://indexed.vc/api/badge/company/intero-biosystems" alt="Intero Biosystems on Indexed.vc" width="260" height="76" /></a>